Clostridium botulinum toxin inhibits myometrial activity in vitro: Possible application on the prevention of preterm labor after fetal surgery

Journal of Pediatric Surgery

Volumn 38, Issue 3, 2003, Pages 511-513

  Garza, Jennifer J ^b   Downard, Cynthia D ^b   Clayton, Nicholas ^b   Maher, Timothy J ^b   Fauza, Dario O ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Botox; Botulinus toxin; Clostridium botulinum; Fetal surgery; Myometrium; Premature labor; Uterus

Indexed keywords

BOTULINUM TOXIN A; BTX A;

ANIMAL TISSUE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS SURGERY; MYOMETRIUM; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; RAT; UTERUS CONTRACTION;

EID: 0037373228     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2003.50090     Document Type: Conference Paper

References (16)

1. Dennes WJB, Bennett PP: Preterm labor: the Achilles heel of fetal intervention, in Harrison MR, Evans MI, Adzick NS (eds): The Unborn Patient. The Art and Science of Fetal Therapy. Philadelphia, PA. Saunders, 2001, pp 171-81
2. Skarsgard ED. El-Sayed YY: New tocolytic strategies for fetal surgery: Efficacy and fetomaternal safety of Nitroglycerin, in Harrison MR, Evans MI, Adzick NS, et al (eds): The Unborn Patient: The Art and Science of Fetal Therapy. Philapdelphia, PA, Saunders, 2001, pp 183-189
3. Fauza DO, Berde CB, Fishman SJ: Prolonged local myometrial blockade prevents preterm labor after fetal surgery in a leporine model. J Pediatr Surg 34:540-542, 1999
4. Eltze M: Proestrus and metestrus rat uterus, a rapid and simple in vitro method for detecting histamine H2-receptor antagonism. Arzneimittelforschung 29:1107-1112, 1979
5. Lemanns C: The most poisonous poison. Science 130:763-772, 1969
6. Schantz EJ, Johnson EA: Botulinum toxin: The story of its development for the treatment of human disease. Perspect Biol Med 40:317-327, 1997
7. Carruthers A, Carruthers J: Botulinum toxin type A: History and current cosmetic use in the upper face. Semin Cutan Med Surg 20:71-84, 2001
8. Klein AW: Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 20:109-20, 2001
9. Albanese A, Bentivoglio AR, Cassetta E, et al: Review article: The use of botuliuum toxin in the alimentary tract. Aliment Pharmacol Ther 9:599-604, 1995
10. Naumann M, Hofmann U, Bergmann I, et al: Focal hyperhidrosis: Effective treatment with intracutaneous botulinum toxin. Arch Dermatol 134:301-304, 1998
11. Brisinda G, Maria G, Bentivoglio AR, et al: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chroaic anal fissure. N Engl J Med 341:65-69, 1999
12. Naver H, Swartling C, Aquilonius SM: Palmar and axillary hyperhidrosis treated with botulinum toxin: One-year clinical followup. Eur J Neurol 7:55-62, 2000
13. Klein AW: Botulinum toxins. Introduction. Semin Cutan Med Surg 20:69-70, 2001
14. Verheyden C, Blitzer A, Brin MF: Other noncosmetic uses of BOTOX. Semin Cutan Med Surg 20:121-126, 2001
15. de Paiva A, Meunier FA, Molgo J, et al: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96:3200-3205, 1999
16. Callaway JE, Arezzo JC, Grethlein AJ: Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology. Semin Cutan Med Surg 20:127-136, 2001